Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. - Wikidata - wikimedia - TriplyDB

Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.

Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.

http://www.wikidata.org/entity/Q53338355

about

Follicular lymphoma: 2012 update on diagnosis and management Role of the tumor microenvironment in mature B-cell lymphoid malignancies Lymphoma Immunotherapy: Current Status Follicular lymphoma: 2011 update on diagnosis and management Follicular lymphoma: 2014 update on diagnosis and management Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma Nature and importance of follicular lymphoma precursors.Infections and Follicular Lymphoma: is there a Link?Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma.Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment.B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression Study of regulatory T-cells in patients with gastric malt lymphoma: influence on treatment response and outcome.Transformation of follicular lymphoma Duodenal follicular lymphoma: comprehensive gene expression analysis with insights into pathogenesis PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival Treatment options for transformed lymphoma: incorporating allogeneic stem cell transplantation in a multimodality approach.Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation Soluble IL-2Rα facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma.Pathophysiology of T follicular helper cells in humans and mice Lectins from opportunistic bacteria interact with acquired variable-region glycans of surface immunoglobulin in follicular lymphoma.Highly clonal regulatory T-cell population in follicular lymphoma - inverse correlation with the diversity of CD8(+) T cells.IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma.Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis.Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells.High ratio of interfollicular CD8/FOXP3-positive regulatory T cells is associated with a high FLIPI index and poor overall survival in follicular lymphoma.Pathogenesis of follicular lymphoma High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells.Follicular lymphoma cells induce changes in T-cell gene expression and function: potential impact on survival and risk of transformation.Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols.Regulating the suppressors: helpful or harmful?Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells.Targeting the follicular lymphoma microenvironment - ready for prime-time?How have outcomes for patients with follicular lymphoma changed with the addition of monoclonal antibodies?Refining the treatment of follicular lymphoma.Dissecting the gray zone between follicular lymphoma and marginal zone lymphoma using morphological and genetic features.A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients.Predicting transformation in follicular lymphoma.The microenvironment in mature B-cell malignancies: a target for new treatment strategies Investigational histone deacetylase inhibitors for non-Hodgkin lymphomas.Management options, survivorship, and emerging treatment strategies for follicular and Hodgkin lymphomas.

P2860

Q22252956-44926FC7-63B8-4C0B-AD99-AB00EA837B6E Q26748775-C4721447-3611-4688-B96B-5BC6C3505BFE Q26782902-1EBB9F8F-7271-4CBC-943C-62A01547CF5D Q26851450-A0939893-7BF2-4362-9BE6-BF465B6C1B8C Q27021850-A6CDFF96-E52D-4779-9999-865A6E58191B Q28276837-2435644E-BB18-421B-BA0B-A14C7B8A1753 Q33558757-FDDA4E1B-32E6-4FAA-9FF2-C7B760CC6136 Q33642185-A24DED81-64C2-483B-80BA-ADDCA326363D Q33759661-34E6C032-4B3E-41B0-B62A-D62645448C23 Q33931720-AE4484DB-AD77-4289-A3C4-5DD00DA1B287 Q34059352-10FB8305-AB3C-46AC-A64E-1CF40B0A9647 Q34532146-C301729A-826A-4202-91DB-AEFEA25E92BB Q35038729-B74DED8C-97B7-426E-B210-DB500A0D0CAB Q35051585-A1F71870-B7E1-41D2-A1AA-5A8AA10E27FD Q35146249-0510EF7B-E037-46C8-A424-C0F5E3CA2357 Q35166811-C297F635-237C-4B37-B623-47926A5850D1 Q35189915-B8241117-6132-4EE5-9135-8CFB3BF22773 Q35212373-2E287E00-3072-47BD-B4EE-30487FF35FCD Q35695090-036291AE-C31D-4AC7-8C3D-83D183C2DBAF Q35786734-C7FB81C2-7E05-4E4D-8A2B-1B2BBEF469D7 Q35798858-D22720C6-3759-4F77-BA1F-9344BAC88F83 Q35858092-4A28E502-C39E-4D53-960B-92E72B32A843 Q35866406-7793E99E-EE56-48C4-8EB5-A518E97EDABB Q36191426-4A0A5166-31F3-420A-B35B-6320BC6DBB0E Q36246716-D6B7131F-2821-47C3-94FF-68BF7523F5CF Q36290288-732407FA-17ED-4AE0-800B-C78DFFC70B1D Q36628291-E07B9EFD-29AE-48EC-80B0-DFD32C722B7B Q37004749-66251E6A-87B9-458C-9D78-39061BCCAE25 Q37059428-6161D97A-AB88-41E0-933C-602A827F48C1 Q37071677-F5DDA8E0-5C52-4C66-B2F0-45CB6E4CD80B Q37073655-80DDA5F8-4D2D-45B7-913F-70532C250DCA Q37157414-4C3145E9-F541-44B2-BB49-73FF5549C000 Q37208506-95E49C27-6903-456C-ADCA-A24DC8964135 Q37280919-6A277D4C-04A9-4369-8517-DA080AE99772 Q37377920-FA7304DA-6A78-4A93-B952-E5B25EC75D0D Q37381683-9C8CE5B8-513A-44BC-9618-4F0D86C35ED7 Q37552778-1B2BC92A-D3B1-4695-BCFC-4E36AEA49D11 Q37563816-32F0FC87-8D29-489F-85A5-6B8E8C54D0CE Q37774667-681852EA-80F5-4D98-8BE8-7BB8F7453A11 Q37775633-CC00FFD7-E455-4824-9838-B744E671F35A

P2860

Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.

http://www.wikidata.org/entity/Q53338355

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Gene-expression and immunohist ...... gnosis of follicular lymphoma.

@en

Gene-expression and immunohist ...... gnosis of follicular lymphoma.

@nl

type

label

Gene-expression and immunohist ...... gnosis of follicular lymphoma.

@en

Gene-expression and immunohist ...... gnosis of follicular lymphoma.

@nl

prefLabel

Gene-expression and immunohist ...... gnosis of follicular lymphoma.

@en

Gene-expression and immunohist ...... gnosis of follicular lymphoma.

@nl

P1433

Q53338355-EFFF02A8-FC3D-4FA6-B3D6-CE8681D0F75F

P1476

Q53338355-1FEBA4D0-530E-4C21-B635-BEDECA964863

P2093

Q53338355-15FFAB53-C8C1-4D87-9C9F-91F361EFC805

Q53338355-186E0F74-C2D9-4DD0-AEE9-388BF11E6F04

Q53338355-267ECAEC-300E-49CE-9B15-054F26FB297E

Q53338355-49BC8516-8621-4D08-96B9-DB51D9E30EE7

Q53338355-539FF880-90AF-4B28-BEE5-D0DA0EFD8A7E

Q53338355-5A73024B-9494-47F8-87B8-C056D6BC41EB

Q53338355-6244F638-29FD-4265-848F-D19A29319BBB

Q53338355-7EF66B26-3FCA-45C5-9528-A516A68A6D98

Q53338355-A9A0C4EE-7DE0-4825-9C54-20C59E7675C7

Q53338355-B5FC5661-9ABC-4E2B-BF2C-209ADD6AF77F

P304

Q53338355-73B3B398-99AC-4683-BE13-9DE6123640CB

P31

Q53338355-24F7DA20-9414-48B5-A8BD-1EC10D02BB86

P356

Q53338355-D7A715BD-5F48-41DA-AE2F-4988196A8C55

P407

Q53338355-9A27B209-7178-4D8C-97DD-65AA10D202BC

P433

Q53338355-70E0423D-E9D5-418B-8F48-AB8B718B4E26

P478

Q53338355-788C397A-5C0F-43E7-9848-1FEF81020184

P50

Q53338355-2A69FA4B-5776-44A2-A8AD-284EF36F1DA3

Q53338355-680D8371-89A2-495C-B42A-29CF0D84BFEC

P577

Q53338355-3520FC8C-01CC-42BC-B6AC-194E0953F3ED

P698

Q53338355-98AB6280-3DA5-4CEB-8829-5D564D554D62

P921

Q53338355-7D94585B-5487-4922-86E9-63D4E46CB450

P356

JCO.2006.06.1648

P1433

Journal of Clinical Oncology

P1476

Gene-expression and immunohist ...... ognosis of follicular lymphoma

@en

P2093

Daphne de Jong

http://www.w3.org/2001/XMLSchema#string

J Han J M van Krieken

http://www.w3.org/2001/XMLSchema#string

John Raemaekers

http://www.w3.org/2001/XMLSchema#string

Joke W Baars

http://www.w3.org/2001/XMLSchema#string

Laura J van't Veer

http://www.w3.org/2001/XMLSchema#string

Laurent Knoops

http://www.w3.org/2001/XMLSchema#string

Leonie Delahaye

http://www.w3.org/2001/XMLSchema#string

Lodewyk A Wessels

http://www.w3.org/2001/XMLSchema#string

Marie José Kersten

http://www.w3.org/2001/XMLSchema#string

Philip M Kluin

http://www.w3.org/2001/XMLSchema#string

P304

390-398

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2006.06.1648

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-01-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17200149

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry